<PAGE> 1
FORM 10-C
Securities and Exchange Commission
Washington, D.C. 20549
Report by issuer of securities quoted on The Nasdaq Stock Market(SM), filed
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule
13a-17 or 15d-17 thereunder.
EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER: Atrix Laboratories, Inc.
-------------------------
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 2579 Midpoint Drive,
----------------------
Fort Collins, CO 80525
----------------------
ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE): (800) 442-8749
--------------
I. Change in Number of Shares Outstanding
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:
1. Title of security Common stock, $.001 par value
-----------------------------
2. Number of shares outstanding before the change 8,492,784
---------
3. Number of shares outstanding after the change 10,742,784
----------
4. Effective date of change May 8, 1996
-----------
5. Method of change Issuance of common stock
------------------------
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.) Common stock
------------
offering
- --------
Give brief description of transaction On May 8, 1996, the Company issued
----------------------------------
2,250,000 shares of common stock pursuant to a common stock offering
- --------------------------------------------------------------------
II. Change in Name of Issuer
1. Name prior to change
--------------------------------------------------
2. Name after change
-----------------------------------------------------
3. Effective date of charter amendment of changing name
------------------
4. Date of shareholder approval of change, if required
-------------------
May 8, 1996 /s/ KIMBERLY A. MARKS
-----------------------------
Kimberly A. Marks,
Corporate Controller
